Quijada-Álamo, M., Hernández-Sánchez, M., Alonso-Pérez, V., Rodríguez-Vicente, A. E., García-Tuñón, I., Martín-Izquierdo, M., . . . Hernández-Rivas, J. M. (2020). CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition. Leukemia.
Chicago-tyylinen lähdeviittausQuijada-Álamo, Miguel, et al. "CRISPR/Cas9-generated Models Uncover Therapeutic Vulnerabilities of Del(11q) CLL Cells to Dual BCR and PARP Inhibition." Leukemia 2020.
MLA-viiteQuijada-Álamo, Miguel, et al. "CRISPR/Cas9-generated Models Uncover Therapeutic Vulnerabilities of Del(11q) CLL Cells to Dual BCR and PARP Inhibition." Leukemia 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.